ArticleMolecules (Basel, Switzerland)2020
Characterization of Volatile Organic Compounds Emitted from Endophytic
Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 56 citations in OpenAlex.
- Separative Techniques Coupled to Mass Spectrometry for Metabolomic Analysis.Advances in experimental medicine and biology · 2026Review
- Ecological Diversity, Metabolic Versatility, and Biotechnological Applications ofAntibiotics (Basel, Switzerland) · 2025Review
- Mining Microbial Niches: Sources of Bacteria for Enhancing Plant Growth and Resilience to pH, Salinity, Drought and Phytophthora infestans.Environmental microbiology reports · 2025Article
- Unveiling the Potential of EndophyticFoods (Basel, Switzerland) · 2025Article
- Complete genome analysis and antimicrobial mechanism ofMicrobiology spectrum · 2025Article
- Actinobacteria Warfare Against the Plant Pathogen Sclerotinia sclerotiorum: 2,4,6-Trimethylpyridine Identified as a Bacterial Derived Volatile With Antifungal Activity.Microbial biotechnology · 2025Article
- Enhancement of production of pathogen-suppressing volatiles using amino acids.Current research in microbial sciences · 2025Article
- Volatile Organic Compounds Produced by Co-Culture ofInternational journal of molecular sciences · 2024Article
- Insights on mining the pangenome ofFrontiers in microbiology · 2024Article
- Investigating the action model of the resistance enhancement induced by bacterial volatile organic compounds againstFrontiers in plant science · 2024Article
- The Wheat EndophyteJournal of fungi (Basel, Switzerland) · 2023Article
- Article
- Manufacture of a Potential Antifungal Ingredient Using Lactic Acid Bacteria from Dry-Cured Sausages.Foods (Basel, Switzerland) · 2023Article
- Compilation of the Antimicrobial Compounds Produced byMolecules (Basel, Switzerland) · 2023Review
- Article
- Inhibitory Effects of Pepper Mild Mottle Virus Infection by Supernatants of Five Bacterial Cultures in Capsicum annuum L.The plant pathology journal · 2022Article
- The Role of Endophytes in Combating Fungal- and Bacterial-Induced Stress in Plants.Molecules (Basel, Switzerland) · 2022Review
- Microbe Related Chemical Signalling and Its Application in Agriculture.International journal of molecular sciences · 2022Review
- The Role of High-Resolution Analytical Techniques in the Development of Functional Foods.International journal of molecular sciences · 2021Review
- Biochemical and structural characterization of two cif-like epoxide hydrolases fromCurrent research in structural biology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 1 institution in 1 country.
Funding
Abstract
The use of antagonistic microorganisms and their volatile organic compounds (VOCs) to control plant fungal pathogens is an eco-friendly and promising substitute for chemical fungicides. In this work, endophytic bacterium ETR-B22, isolated from the root of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.